AGEN

Agenus Inc

Company with tickers: AGEN

CIK

1098972

CUSIP

00847G804

Shares Outstanding

41,642,431

Website

https://www.agenusbio.com

Investor Relations

https://investor.agenusbio.com/overview/default.aspx

13F Activity (30d)

2 filings 1 filers

Press releases and events scraped from the company's investor relations website. News and event listings link back to the original source.

Recent news

Date	Headline
2026-06-02	Agenus Announces Virtual 2026 Annual Shareholders Meeting
2026-05-21	Agenus Presents Phase 2 BOT+BAL Melanoma Data Showing Durable Responses and Meaningful Survival in Advanced Checkpoint-Refractory Melanoma at ASCO 2026
2026-05-21	Agenus and Noetik Present ASCO 2026 Data Linking AI Analysis of Routine Pretreatment Tumor Pathology Images to Response and Survival with BOT+BAL in MSS Metastatic CRC
2026-05-15	Agenus Announces Publication of Phase 1b Botensilimab and Balstilimab Data in Post-Immunotherapy Hepatocellular Carcinoma in Liver Cancer
2026-05-11	Agenus Reports First Quarter 2026 Financial Results and Highlights BOT+BAL Execution Across Global Access and Phase 3 Development
2026-05-04	Agenus to Provide First Quarter 2026 Financial Report and Corporate Update
2026-04-21	Agenus to Present First Phase 2 Botensilimab Data in Advanced Cutaneous Melanoma at ASCO 2026
2026-04-21	Agenus Names BAP Pharma as Exclusive Global Partner for BOT+BAL Access Programs
2026-04-17	Agenus Reports Phase II Data Demonstrating Immune Reprogramming and Durable Survival with Botensilimab, Balstilimab and agenT-797 in PD-1 Refractory Gastroesophageal Cancer
2026-04-03	Agenus Announces Data from Phase II Study of BOT+BAL in Combination with agent-797 in PD-1 Refractory Gastroesophageal Cancer to be Presented at AACR 2026

Past events

Date	Event	Type
2026-06-16	Agenus Annual Virtual Shareholder Meeting \| 2026	Shareholder meeting
2026-06-16	Agenus Annual Virtual Shareholder Meeting \| 2026	Shareholder meeting
2026-03-31	Agenus Stakeholder Webcast March 2026 \| Access and Execution	Webcast
2026-01-28	Agenus Stakeholder Webcast January 2026 \| Access to Acceleration: Agenus’ BOT+BAL Global Momentum Entering 2026	Webcast
2025-12-03	Agenus End of Year 2025 Stakeholder Briefing Webcast	Webcast
2025-10-21	Agenus October 2025 Stakeholder Briefing Webcast- Global Momentum: BOT/BAL Across Borders	Webcast
2025-09-09	H.C. Wainwright 27th Annual Global Investment Conference- Fireside Chat	Conference
2025-08-27	Stakeholder Webcast Participation Details	Webcast
2025-06-03	Markets Briefing on Agenus and Zydus Strategic Partnership	Event
2025-05-12	Agenus First Quarter 2025 Financial Results	Event
2025-03-11	Agenus Fourth Quarter and Year End 2024 Financial Results	Event
2024-11-12	Agenus Third Quarter 2024 Results	Event
2024-10-17	STAT Summit	Event
2024-09-09	H.C. Wainwright 26th Annual Global Investment Conference	Conference
2024-09-05	Wells Fargo 2024 Healthcare Conference	Conference
2024-08-08	Agenus Second Quarter 2024 Results	Event
2024-06-12	Goldman Sachs 45th Annual Global Healthcare Conference	Conference
2024-06-11	Agenus 2024 Virtual Annual Shareholder Meeting	Shareholder meeting
2024-05-07	Agenus First Quarter 2024 Results	Event
2024-03-14	Agenus Fourth Quarter and Year End 2023 Financial Results	Event
2024-03-11	Leerink Partners Global Biopharma Conference	Conference
2024-02-14	Oppenheimer 34th Annual Healthcare Life Sciences Conference	Conference
2024-01-18	B Riley Healthcare Conference	Conference
2023-11-07	Agenus Third Quarter 2023 Financial Results	Event
2023-10-22	Corporate Event at ESMO 2023	Event

Source: https://investor.agenusbio.com/overview/default.aspx